A study to investigate safety, tolerability, and pharmacokinetics of AZD3974 in healthy participants

Trial Identifier:	D7360C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	December 2025
Primary Completion Date:	October 2026
Study Completion Date:	October 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206
US, MD	Baltimore, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.